Scientists generated induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells via nucleofection with episomal plasmids. The patient-specific iPSCs were edited via CRISPR/Cas9 technology to generate gene-corrected isogenic iPSCs.
[Cell Death & Disease]